Check Cap Ltd - Asset Resilience Ratio
Check Cap Ltd (CHEK) has an Asset Resilience Ratio of 0.00% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore Check Cap Ltd balance sheet assets for the complete picture of this company's asset base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2023)
This chart shows how Check Cap Ltd's Asset Resilience Ratio has changed over time. See CHEK net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Check Cap Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Check Cap Ltd (CHEK) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Check Cap Ltd maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Check Cap Ltd Industry Peers by Asset Resilience Ratio
Compare Check Cap Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882 |
Diagnostics & Research | 0.14% |
|
SMO ClinPlus Co. Ltd.
SHE:301257 |
Diagnostics & Research | 15.78% |
|
Healius Ltd
AU:HLS |
Diagnostics & Research | 0.06% |
|
RHYTHM Biosciences Ltd
AU:RHY |
Diagnostics & Research | 2.74% |
|
Check-Cap Ltd.
NASDAQ:MBAI |
Diagnostics & Research | 2.90% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
Annual Asset Resilience Ratio for Check Cap Ltd (2012–2023)
The table below shows the annual Asset Resilience Ratio data for Check Cap Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 63.60% | $15.91 Million | $25.02 Million | -19.16pp |
| 2022-12-31 | 82.76% | $37.61 Million | $45.44 Million | +37.66pp |
| 2021-12-31 | 45.10% | $25.10 Million | $55.66 Million | -6.22pp |
| 2020-12-31 | 51.32% | $10.08 Million | $19.64 Million | +51.32pp |
| 2019-12-31 | 0.00% | $11.00 | $9.43 Million | -36.56pp |
| 2018-12-31 | 36.56% | $5.64 Million | $15.44 Million | +35.86pp |
| 2017-12-31 | 0.70% | $55.00K | $7.91 Million | +0.24pp |
| 2016-12-31 | 0.46% | $56.00K | $12.29 Million | -30.99pp |
| 2015-12-31 | 31.45% | $4.81 Million | $15.30 Million | +30.90pp |
| 2014-12-31 | 0.55% | $43.00K | $7.79 Million | -0.30pp |
| 2013-12-31 | 0.86% | $46.00K | $5.38 Million | -39.75pp |
| 2012-12-31 | 40.61% | $3.45 Million | $8.50 Million | -- |
About Check Cap Ltd
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company was incorporated in 2004 and is based in Isfiya, Israel.